pbs tirzepatide Pharmaceutical giants Eli Lilly, Novo Nordisk push for weight-loss drugs Mounjaro and Ozempic to be added to InVivoSIM GIPR/GLP‑1R Dual Agonist (Tirzepatide

A total of 16% of the 1049 patients had taken silymarin in the past, with an average treatment lasting 6 months, and 16% had been taking it at the time of the baseline examination for an average of 35 months

Semaglutide in Obesity Treatment New results from the SURMOUNT-5 trial pit tirzepatide against semaglutide in adults with obesity (no diabetes), revealing greater weight loss with the Obesity treatment is being revolutionized by a new class of medications that deliver unprecedented weight loss

doi: 10.1002/jemt.20823 227 CalkinsKDevaskarSU

Thailand Slim focuses on physician-supervised information and consultation pathways so eligible patients can better understand their options in a responsible and medically appropriate way

Cell Metab 31(6):1189-1205.e13